Aligos Therapeutics to Present Data from Chronic Hepatitis

SOUTH SAN FRANCISCO, Calif., April 11, 2023 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS), a clinical stage biopharmaceutical company...

Related Keywords

Austria ,Russia ,Vienna ,Wien ,Ukraine ,Jin Hong ,Lawrence Blatt ,Alina Jucov ,Corey Davis ,Kusum Gupta ,Jinlin Hou ,Yannick Debing ,Amy Jobe ,Tongfei Wu ,Nasdaq ,Exchange Commission ,Exchange Commission On ,Aligos Therapeutics Inc ,Lifesci Communications ,European Association ,Scientific Presentations ,Securities Litigation Reform Act ,Aligo Annual Report ,Nasdaq Algs ,Aligos Therapeutics ,